Study finds kit differences in equine embryo vitrification
Bottom line
A new study in Equine Veterinary Journal compared three commercial human embryo vitrification kits for cryopreserving in vivo produced equine embryos and found that kit choice may matter most for larger embryos. Sandra Wilsher and colleagues at Sharjah Equine Hospital evaluated Kitazato, Vit Kit Freeze, and Vit Kit Freeze NX, all of which use the same penetrating cryoprotectants but differ in their non-penetrating components. The study reported similar pregnancy rates across kits for embryos up to 400 μm, but better outcomes with the Kitazato kit for embryos measuring 400–500 μm. The paper builds on earlier work showing that embryo size is a major determinant of equine vitrification success. (colab.ws)
Why it matters: For equine reproduction teams, the findings suggest vitrification protocols shouldn't be treated as interchangeable, especially when working with larger embryos that are traditionally harder to freeze successfully. Prior reviews and conference updates from Wilsher have emphasized that equine embryos become more difficult to cryopreserve as they expand, because their large blastocoele and capsule complicate both vitrification and warming. If one commercially available kit performs better in the 400–500 μm range, that could influence protocol selection, recipient mare planning, and how practices counsel pet parents and breeders about expected pregnancy rates after embryo transfer. (colab.ws)
What to watch: Watch for follow-up data on live foal rates, broader field validation, and whether clinics begin favoring specific kits for larger equine embryos. (colab.ws)
Key facts
- Study
- Compared three commercial human embryo vitrification kits for in vivo produced equine embryos
- Kits studied
- Kitazato, Vit Kit Freeze, and Vit Kit Freeze NX
- Shared cryoprotectants
- Dimethyl sulfoxide and ethylene glycol
- Size finding
- Similar pregnancy rates up to 400 μm
- Larger embryo finding
- Kitazato performed better for 400–500 μm embryos
- Study context
- Published in Equine Veterinary Journal
- Main takeaway
- Kit choice may matter most for larger equine embryos
A new Equine Veterinary Journal study adds practical detail to a familiar challenge in equine reproduction: freezing horse embryos is possible, but success still depends heavily on embryo size. In the new comparison, Sandra Wilsher and colleagues found that three commercial human embryo vitrification kits produced comparable pregnancy rates for smaller in vivo produced equine embryos, while the Kitazato kit outperformed the other two for larger embryos in the 400–500 μm range. (colab.ws)
That result fits with a longer arc in the literature. Vitrification has increasingly replaced slow freezing for many equine embryo applications because it avoids the need for a programmable freezer and can achieve very rapid cooling rates. But equine embryos present a specific technical problem: once they enter the uterus, they expand quickly, develop a large blastocoelic cavity, and are surrounded by a distinctive capsule, all of which make larger embryos harder to dehydrate, freeze, warm, and re-expand successfully. Wilsher has repeatedly highlighted that “size really does matter” in this setting, both in review work and conference presentations. (ivis.org)
According to the study abstract and associated indexing records, the three kits shared the same penetrating cryoprotectants, dimethyl sulfoxide and ethylene glycol, but differed in their non-penetrating cryoprotectants, including sucrose, trehalose, dextran serum supplement, and hydroxypropyl cellulose. That distinction appears to be the point of the paper: not whether vitrification works at all, but whether the supporting formulation around the standard cryoprotectants changes embryo survival after warming and transfer. The apparent advantage for Kitazato in larger embryos suggests that trehalose and hydroxypropyl cellulose may better support embryos at the upper end of the study's size range, though that mechanistic interpretation remains an inference rather than a direct finding of the trial. (colab.ws)
The study also stands out because it tested human assisted-reproduction products in an equine clinical context. That isn't entirely surprising: commercial vitrification systems developed for human IVF are already widely available, standardized, and familiar to embryo labs. Fujifilm Irvine Scientific, for example, has marketed the newer Vit Kit Freeze NX for human oocyte and embryo vitrification, underscoring how quickly product updates can enter the assisted-reproduction marketplace. For equine clinicians, though, the relevant question is not product novelty but whether formulation changes translate into better pregnancy outcomes in mares. (fujifilmbiosciences.fujifilm.com)
Outside commentary specific to this paper was limited in public sources, but the broader industry conversation has been consistent: larger equine embryos remain the toughest candidates for cryopreservation, and protocol refinements around collapse, warming, and media composition can materially affect outcomes. Earlier studies have explored simplified warming systems, blastocoele manipulation, and vitrification of expanded blastocysts, all aimed at improving survival beyond the smallest embryo stages. In that context, the new head-to-head kit comparison is useful because it addresses a practical lab decision rather than a purely experimental technique. (sciencedirect.com)
Why it matters: For veterinary professionals involved in theriogenology and equine embryo transfer, this is a protocol-selection story as much as a research story. If pregnancy rates are equivalent for embryos up to 400 μm, clinics may have flexibility in kit choice for routine cases. But if larger embryos do better with one kit, that could shape how labs triage embryos, when they choose to vitrify, how they standardize warming procedures, and how they set expectations with pet parents and breeding clients. Even modest improvements in the large-embryo category could expand the number of embryos considered worth freezing rather than transferring fresh or discarding. (colab.ws)
What to watch: The next questions are whether the findings hold up in larger, multi-center datasets, whether live birth or foaling outcomes mirror the pregnancy data, and whether embryo-size thresholds for kit selection become part of standard operating procedures in equine reproduction labs. Recent work in equine IVF and cryopreservation suggests the field is moving toward more clinically oriented outcome reporting, which should make those comparisons easier to judge over time. (pubmed.ncbi.nlm.nih.gov)